Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7298
    -0.0022 (-0.31%)
     

  • CRUDE OIL

    82.80
    -0.56 (-0.67%)
     

  • Bitcoin CAD

    87,739.70
    -3,161.29 (-3.48%)
     

  • CMC Crypto 200

    1,381.17
    -42.93 (-3.02%)
     

  • GOLD FUTURES

    2,327.50
    -14.60 (-0.62%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ

    15,712.75
    +16.11 (+0.10%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6818
    -0.0018 (-0.26%)
     
MARKETS LIVE BLOG:

STOCKS SHED GAINS, TESLA SURGES DAY AFTER EARNINGS

Tesla shares jump after EV maker vows to speed up launch of more affordable models

Today's Research Reports on Fennec Pharmaceuticals, CRH Medical, Cotinga Pharmaceuticals and Baylin Technologies

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / September 27, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Fennec Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=FRX.TO

CRH Medical Corporation
https://rdinvesting.com/news/?ticker=CRH.TO

Cotinga Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=COT.V

Baylin Technologies Inc.
https://rdinvesting.com/news/?ticker=BYL.TO

ADVERTISEMENT

Fennec Pharmaceuticals’ stock moved 2.18% lower Wednesday, to close the day at $10.76. The stock recorded a trading volume of 600 shares, which was below its three months average volume of 2,085 shares. In the last year, Fennec Pharmaceuticals' shares have traded in a range of 9.95 - 18.86. The share price has gained 8.14% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $11.98 is lower than its 200-day moving average of $13.77. Shares of Fennec Pharmaceuticals have fallen approximately 13.85 percent year-to-date.

Access RDI's Fennec Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=FRX.TO

On Wednesday, shares of CRH Medical recorded a trading volume of 138,107 shares, which was below the three months average volume of 195,944 shares. The stock ended the day 0.19% lower at $5.22. The share price has fallen 11.68% from its 52 week high with a 52 week trading range of 1.86 - 5.91. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $5.24 is greater than its 200-day moving average of $4.34. Shares of the company are trading at a Price to Earnings ratio of 47.45. Shares of CRH Medical have gained approximately 57.7 percent year-to-date.

Access RDI's CRH Medical Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CRH.TO

Cotinga Pharmaceuticals’ stock had no change Wednesday, to close the day at $0.12. The stock recorded a trading volume of 17,100 shares, which was below its three months average volume of 44,469 shares. In the last year, Cotinga Pharmaceuticals' shares have traded in a range of 0.10 - 1.50. The share price has gained 20% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.34 is lower than its 200-day moving average of $0.48. Shares of Cotinga Pharmaceuticals have fallen approximately 89.09 percent year-to-date.

Access RDI's Cotinga Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=COT.V

On Wednesday, shares of Baylin Technologies recorded a trading volume of 48,995 shares, which was above the three months average volume of 25,988 shares. The stock ended the day 0.5% lower at $4.00. The share price has fallen 2.91% from its 52 week high with a 52 week trading range of 1.90 - 4.12. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $3.54 is greater than its 200-day moving average of $3.49. Shares of Baylin Technologies have gained approximately 16.28 percent year-to-date.

Access RDI's Baylin Technologies Inc. Research Report at:
https://rdinvesting.com/news/?ticker=BYL.TO

Our Actionable Research on Fennec Pharmaceuticals Inc. (TSX:FRX.TO), CRH Medical Corporation (TSX:CRH.TO), Cotinga Pharmaceuticals Inc. (TSXV:COT.V) and Baylin Technologies Inc. (TSX:BYL.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com